Literature DB >> 18510690

Von Willebrand disease and angiodysplasia responding to atorvastatin.

Mamta Sohal, Mike Laffan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18510690     DOI： 10.1111/j.1365-2141.2008.07005.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  New therapies for von Willebrand disease.

Authors:  Pier Mannuccio Mannucci
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Management of rare acquired bleeding disorders.

Authors:  Marzia Menegatti; Eugenia Biguzzi; Flora Peyvandi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  New therapies for von Willebrand disease.

Authors:  Pier Mannuccio Mannucci
Journal:  Blood Adv       Date:  2019-11-12

Review 4.  von Willebrand factor regulation of blood vessel formation.

Authors:  Anna M Randi; Koval E Smith; Giancarlo Castaman
Journal:  Blood       Date:  2018-06-04       Impact factor: 22.113

5.  Recombinant von Willebrand factor for severe gastrointestinal bleeding unresponsive to other treatments in a patient with type 2A von Willebrand disease: a case report.

Authors:  Racquel Brown
Journal:  Blood Coagul Fibrinolysis       Date:  2017-10       Impact factor: 1.276

Review 6.  Current and Emerging Options for the Management of Inherited von Willebrand Disease.

Authors:  Jessica M Heijdra; Marjon H Cnossen; Frank W G Leebeek
Journal:  Drugs       Date:  2017-09       Impact factor: 9.546

Review 7.  Von Willebrand factor, angiodysplasia and angiogenesis.

Authors:  Anna M Randi; Mike A Laffan; Richard D Starke
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

Review 8.  How I manage severe von Willebrand disease.

Authors:  Frank W G Leebeek; Ferdows Atiq
Journal:  Br J Haematol       Date:  2019-09-09       Impact factor: 6.998
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.